Imagine you’re waking up one day.

As you’re rubbing the sleep from your eyes, you realize your room looks a little fuzzy. The lines of your dresser are distorted. The room’s corners are masked in shadows.

Your sight problems don’t get better over the next few days, so you rush to the hospital. After a few tests, a weary doctor lets you know you have a chronic eye disease.

“Don’t worry, it’s treatable,” the doctor reassures you. “Let’s just do a few more scans. Be sure to come back for follow-ups.”

OK, not terrible … but there’s a problem. Eye-clinic attendance has been increasing over the last decade as the global population ages.

The World Bank shows a steady rise in people over 65 since 1960. Meanwhile, research shows the 65-and-up population will nearly double by 2050.

Doctors are becoming increasingly overstretched, particularly at eye clinics.

You find you can’t confirm your next eye exam since the clinic keeps delaying them. Your vision gets worse … and worse.

And you’re just one of many.

Countless people experience irreversible eye damage every year. And that’s thanks in part to increased demand on clinics that don’t have resources to keep up.

But there’s a rapidly developing industry that has the answer…

A Massive Breakthrough for Eye Care

Meet Google’s artificial intelligence (AI) company DeepMind.

Google took over the British business back in 2014. It’s had a host of successes in the years since, along with some stumbles.

And a couple of months ago, it published some impressive ophthalmology research.

DeepMind announced it created an AI that can detect 50 types of eye disease from simply analyzing a 3D retinal scan. After training on a database of almost 15,000 eye scans, it can also recommend the best treatments with an accuracy rate of 94%.

Better yet, it can explain its findings. That’s a massive breakthrough.

Remember, IBM pitched its supercomputer Watson as a revolution in cancer care. But physicians encountered the “black box” problem: If they didn’t understand what went into Watson’s deep-learning algorithms … they didn’t trust recommendations spit out from the “mysterious black box.”

DeepMind is able to get around that issue. The AI can even calculate its confidence with a percentage score.

That’s great news for the over 285 million people globally who live with some sort of sight loss.

And it’s just one example of how AI technology is revolutionizing our way of life.

The Artificial Intelligence Revolution Is Ramping Up

The world’s leading researchers estimate AI technology (from the robots themselves to the pieces that go into robots) will explode from a $20 billion industry into a $15.7 trillion one in the next five years.

That’s 76,000% growth.

Already, we’re seeing record robotics sales. In 2017, global robotics numbers totaled 387,000, a massive 32% rise from 2016. To put it in perspective, that’s about 10 times higher than the average growth of the S&P 500 Index.

And it’s why big money is piling in, trying to catch this booming industry at its beginning stages:

  • Microsoft has dedicated $12 billion to it.
  • IBM is investing $15 billion.
  • Google is spending $30 billion.
  • Intel has already put up $32 billion to acquire multiple startups in this space.

The list goes on and on.

It’s undeniably time to zero in on this market if you haven’t already. That’s why I urge you to keep this trend on your radar.

We’ll be reporting on the AI market more in the coming weeks. So be sure to check back in to find out the best ways to profit.

In the meantime, I suggest looking into Japan. Our systems expert Ian Dyer reports: “As of last November, 52% of robots were made there. So, right now it’s far and away the leader in the field.”

To invest in Japan, he recommends buying the WisdomTree Japan Hedged Equity ETF (NYSE: DXJ). The fund holds over 250 Japanese stocks with a focus on auto companies.

Auto is the leading industry in adopting robotic technology, so this is an ideal fund to park some cash.


Jessica Cohn-Kleinberg

Managing Editor, Banyan Hill Publishing